This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2003 Dec 6;362(9399):1937.

doi: 10.1016/S0140-6736(03)14976-8.

Combine EUROPA and HOPE

PMID: 14667761
DOI: 10.1016/S0140-6736(03)14976-8

Comparative Study

Combine EUROPA and HOPE

John A Fuller. Lancet. 2003.

. 2003 Dec 6;362(9399):1937.

doi: 10.1016/S0140-6736(03)14976-8.

Author

PMID: 14667761
DOI: 10.1016/S0140-6736(03)14976-8

No abstract available

PubMed Disclaimer

Comment on

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).
Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Fox KM, et al. Lancet. 2003 Sep 6;362(9386):782-8. doi: 10.1016/s0140-6736(03)14286-9. Lancet. 2003. PMID: 13678872 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science